Medicare spending on cancer drugs may not be associated with the drugs’ clinical benefits, such as overall survival or progression-free survival.

Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of ...

An analysis of oncology drugs approved in the United States found that Medicare spending was predominantly driven by the market, not a drug’s therapeutic value.

Tradjenta -- A prescription medicine that is used to treat type 2 diabetes. Otezla – A prescription pill that treats plaque ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

Semaglutide (Ozempic) is 1 of 15 medications that will be included in yearly price negotiations between Medicare and ...

Medicare will negotiate drug prices for popular medications like Ozempic and Wegovy, aiming to save billions for taxpayers ...

Shares of Guardant Health (NASDAQ:GH) have increased by 5.0% in premarket trading Tuesday following the company's ...

NEW YORK – Guardant Health announced Tuesday that its Guardant Reveal liquid biopsy test has received coverage from Medicare administrative contractor Palmetto GBA to monitor colorectal cancer ...